Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus.
- 1 March 2000
- journal article
- clinical trial
- Published by Wiley in International Journal of Dermatology
- Vol. 39 (3) , 218-222
- https://doi.org/10.1046/j.1365-4362.2000.00953.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skinArchives of Dermatology, 1995
- The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell culturesClinical and Experimental Immunology, 1995
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Tumor necrosis factorJournal of the American Academy of Dermatology, 1991
- Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitisArchives of Dermatology, 1990
- Thalidomide-induced peripheral neuropathy. Effect of serum factor on nerve culturesArchives of Dermatology, 1984
- Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosusBritish Journal of Dermatology, 1983
- Thalidomide treatment of subacute cutaneous lupus erythematosusBritish Journal of Dermatology, 1982
- Treatment of prurigo nodularis with thalidomideArchives of Dermatology, 1980
- THALIDOMIDE IN THE TREATMENT OF ACTINIC PRURIGOInternational Journal of Dermatology, 1973